Generic medicines account for the vast majority of listed chemicals in China.Due to generic drugs are of variable quality

directly affects people's medication safety and effectiveness

at present

our country puts forward to improve the quality of generic drugs comprehensively

it is an important strategic opportunity for the pharmaceutical industry to evaluate the consistency of the quality of generic drugs and reference drugs in batches.Under the market-oriented

guide enterprises to participate in the construction of bioequivalence (BE) research platform through the way of horizontal cooperation and enterprises as the main body.The reference preparation and the information sharing mechanism for the consistency evaluation of generic drugs was established by the joint venture.At the same time

through the government to guide the allocation of resources

and take care of the central and western regions to solve the practical problems faced by pharmaceutical companies in central and western regions

in order to realize the regional balanced development of the pharmaceutical industry and promote the supply-side reform of the pharmaceutical industry.